Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP269529.RAcxTzBn5vKYdM_emqmi0CN3u7latQeul51Vu1s2CELZM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP269529.RAcxTzBn5vKYdM_emqmi0CN3u7latQeul51Vu1s2CELZM130_assertion type Assertion NP269529.RAcxTzBn5vKYdM_emqmi0CN3u7latQeul51Vu1s2CELZM130_head.
- NP269529.RAcxTzBn5vKYdM_emqmi0CN3u7latQeul51Vu1s2CELZM130_assertion wasGeneratedBy ECO_0000203 NP269529.RAcxTzBn5vKYdM_emqmi0CN3u7latQeul51Vu1s2CELZM130_provenance.
- NP269529.RAcxTzBn5vKYdM_emqmi0CN3u7latQeul51Vu1s2CELZM130_assertion wasDerivedFrom befree-20150227 NP269529.RAcxTzBn5vKYdM_emqmi0CN3u7latQeul51Vu1s2CELZM130_provenance.
- NP269529.RAcxTzBn5vKYdM_emqmi0CN3u7latQeul51Vu1s2CELZM130_assertion SIO_000772 20573596 NP269529.RAcxTzBn5vKYdM_emqmi0CN3u7latQeul51Vu1s2CELZM130_provenance.
- NP269529.RAcxTzBn5vKYdM_emqmi0CN3u7latQeul51Vu1s2CELZM130_assertion evidence source_evidence_literature NP269529.RAcxTzBn5vKYdM_emqmi0CN3u7latQeul51Vu1s2CELZM130_provenance.
- NP269529.RAcxTzBn5vKYdM_emqmi0CN3u7latQeul51Vu1s2CELZM130_assertion description "[Post-treatment circulating plasma BMP6 mRNA and H3K27 methylation levels discriminate metastatic prostate cancer from localized disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP269529.RAcxTzBn5vKYdM_emqmi0CN3u7latQeul51Vu1s2CELZM130_provenance.